10X Genomics - 92 Competitors and alternatives in Sep 2024 - Tracxn (2024)

Developer of benchtop DNA sequencer for research applications. The company offers an AVITI benchtop sequencer that delivers high data quality through enhanced contrast-to-noise ratio (CNR) for the research and diagnostic markets.

Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.

Developer of multiplexed single-cell analysis tools for diagnostics and life science research. Their specialties include 'secretome analysis for applications in immune monitoring, vaccine response evaluation, personalized medicine, adoptive immune therapies, stem cell research, and oncology.

DNAnudge develops genetic testing solutions for nutrition. Its flagship device analyzes customer saliva samples for single nucleotide polymorphisms (SNPs) that have been linked to metabolism, including parameters such as the ability to metabolize sugar and fat, absorb vitamins and to assess predisposition to obesity and diabetes. Users can buy disposable cartridges, load them with their saliva samples and insert into the flagship semiconductor-based device NudgeBox. The NudgeBox will analyze the genomic data, convert into barcodes and link it with a mobile app. Customers can then use this app to scan barcodes of food items and receive nutritional information customized according to their genetic profile.

Manufacturer of a medical device for cell-based therapy. The company offers Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. It also, offers software suite for cell therapy modalities.

Developer of cell culture analysis device for cancer research. The platform technology Avatar mimics in vivo physiological conditions for reproducible and more accurate in vitro tests. It allows for the preferential isolation and expansion of circulating tumor cells in the patient's blood. The company also provides cell-binding substrates and culture media to use in conjunction with its platform. The company has developed a cell analysis tool which is AI enables and assists with real-time analysis of cell health for identifying cell kinetics, targets, and other immunotherapy research.

Developer of single-cell imaging and profiling platform based on magnetic levitation technology. The company is developing a single-cell imaging and profiling platform based on magnetic levitation technology called the levitation image cytometry platform. The company claims that it would be a label-free & universal method of cell analysis. This platform will be used in therapeutics, diagnostic & research applications.

Manufacturer of optical tweezers for single-molecule analysis instruments. The product portfolio of the company includes C-Trap, an integrated system with optical tweezers, a confocal microscope, and a microfluidic system to analyze protein folding, DNA repair, DNA organization, Protein polymer, and filaments. Its product, AFS-acoustic force spectroscopy (a single molecule manipulation system), and u-Flux (an integrated microfluidic system) are used in performing experiments in a laminar flow environment.

Developer of Single-cell analysis systems for biologics discovery. The company's products use proprietary picodroplet technology for single-cell analysis. Applications include drug discovery & development, bioproduction & synthetic biology, cell therapy engineering, analysis & isolation, metagenomics, and single-cell disease research & diagnostics.

Developer of miniature robots for drug delivery. It offers advanced remote control and imaging system that helps in drug delivery to targeted disease areas and helps in the treatment of brain disorders. It also provides technology for gene therapy, CRISPR-Cas9, and oncolytic viruses.